A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan

Ming Chyi Huang, Chun Hsin Chen, Jeng Ming Yu, Chiao Chicy Chen

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The aim of this study was to investigate the effectiveness of naltrexone in Taiwanese Han males with alcohol dependence. In conjunction with limited supportive psychotherapy, 40 alcoholic patients, who met Diagnostic and Statistical Manual version III revised (DSM-III-R) criteria for alcohol dependence, were assigned to a randomized double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/day) for 14 weeks following alcohol detoxification. Among recruited patients, 45% (n = 9/20) of the naltrexone-treated subjects and 35% (n = 7/20) of the placebo-treated subjects dropped out (p = 0.374). The relapse rates between the two groups were not significant (p = 0.671). Subjects taking naltrexone reported less alcohol craving compared with placebo-treated subjects. In support of previous reports, the present results suggest that naltrexone may be safe and effective in craving reduction in alcohol-dependent subjects.

Original languageEnglish
Pages (from-to)289-292
Number of pages4
JournalAddiction Biology
Volume10
Issue number3
DOIs
Publication statusPublished - Sep 2005

Fingerprint

Naltrexone
Taiwan
Alcoholism
Placebos
Alcohols
Therapeutics
Alcoholics
Psychotherapy
Recurrence

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan. / Huang, Ming Chyi; Chen, Chun Hsin; Yu, Jeng Ming; Chen, Chiao Chicy.

In: Addiction Biology, Vol. 10, No. 3, 09.2005, p. 289-292.

Research output: Contribution to journalArticle

Huang, Ming Chyi ; Chen, Chun Hsin ; Yu, Jeng Ming ; Chen, Chiao Chicy. / A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan. In: Addiction Biology. 2005 ; Vol. 10, No. 3. pp. 289-292.
@article{03e1ee506d924642b6bf114162cfa0ee,
title = "A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan",
abstract = "The aim of this study was to investigate the effectiveness of naltrexone in Taiwanese Han males with alcohol dependence. In conjunction with limited supportive psychotherapy, 40 alcoholic patients, who met Diagnostic and Statistical Manual version III revised (DSM-III-R) criteria for alcohol dependence, were assigned to a randomized double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/day) for 14 weeks following alcohol detoxification. Among recruited patients, 45{\%} (n = 9/20) of the naltrexone-treated subjects and 35{\%} (n = 7/20) of the placebo-treated subjects dropped out (p = 0.374). The relapse rates between the two groups were not significant (p = 0.671). Subjects taking naltrexone reported less alcohol craving compared with placebo-treated subjects. In support of previous reports, the present results suggest that naltrexone may be safe and effective in craving reduction in alcohol-dependent subjects.",
author = "Huang, {Ming Chyi} and Chen, {Chun Hsin} and Yu, {Jeng Ming} and Chen, {Chiao Chicy}",
year = "2005",
month = "9",
doi = "10.1080/13556210500223504",
language = "English",
volume = "10",
pages = "289--292",
journal = "Addiction Biology",
issn = "1355-6215",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan

AU - Huang, Ming Chyi

AU - Chen, Chun Hsin

AU - Yu, Jeng Ming

AU - Chen, Chiao Chicy

PY - 2005/9

Y1 - 2005/9

N2 - The aim of this study was to investigate the effectiveness of naltrexone in Taiwanese Han males with alcohol dependence. In conjunction with limited supportive psychotherapy, 40 alcoholic patients, who met Diagnostic and Statistical Manual version III revised (DSM-III-R) criteria for alcohol dependence, were assigned to a randomized double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/day) for 14 weeks following alcohol detoxification. Among recruited patients, 45% (n = 9/20) of the naltrexone-treated subjects and 35% (n = 7/20) of the placebo-treated subjects dropped out (p = 0.374). The relapse rates between the two groups were not significant (p = 0.671). Subjects taking naltrexone reported less alcohol craving compared with placebo-treated subjects. In support of previous reports, the present results suggest that naltrexone may be safe and effective in craving reduction in alcohol-dependent subjects.

AB - The aim of this study was to investigate the effectiveness of naltrexone in Taiwanese Han males with alcohol dependence. In conjunction with limited supportive psychotherapy, 40 alcoholic patients, who met Diagnostic and Statistical Manual version III revised (DSM-III-R) criteria for alcohol dependence, were assigned to a randomized double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/day) for 14 weeks following alcohol detoxification. Among recruited patients, 45% (n = 9/20) of the naltrexone-treated subjects and 35% (n = 7/20) of the placebo-treated subjects dropped out (p = 0.374). The relapse rates between the two groups were not significant (p = 0.671). Subjects taking naltrexone reported less alcohol craving compared with placebo-treated subjects. In support of previous reports, the present results suggest that naltrexone may be safe and effective in craving reduction in alcohol-dependent subjects.

UR - http://www.scopus.com/inward/record.url?scp=24944492107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944492107&partnerID=8YFLogxK

U2 - 10.1080/13556210500223504

DO - 10.1080/13556210500223504

M3 - Article

C2 - 16109592

AN - SCOPUS:24944492107

VL - 10

SP - 289

EP - 292

JO - Addiction Biology

JF - Addiction Biology

SN - 1355-6215

IS - 3

ER -